Raymond James: Village Farms Expected To Post 15% Revenue Increase In Q3

Last night, Raymond James came out with their third quarter estimates for Village Farms (TSX: VFF) (NASDAQ: VFF) whom is anticipated to be reporting its results the week of November 10th. Raymond James currently has a $20 price target and an Outperform rating on the stock.

Rahul Sarugaser, Raymond James’ cannabis analyst, headlines the note, “+15% Rev., 8th Straight +EBITDA Q | 1Q21 Catalyst: Consolidating PSF Revenue.” Sarugaser says, based on their data, Village’s Pure Sunfarms is continuing to ramp up revenue as it has a roughly 40% market share in Ontario. Pure Sunfarms accounts for approximately 6% of all Canadian adult-use cannabis. With this in mind, Sarugaser is guiding Pure Sunfarms revenue to grow to $10.8 million.

Another critical metric Sarugaser points to is Pure Sunfarms “industry-leading cultivation costs.” Sunfarms’ all-in cost of goods sold is C$0.80 per gram, with the second place low cost producer sitting at C$1.40, which is nearly double theirs. Sarugaser says that this cost of goods sold will “drive an industry-best 8th consecutive EBITDA-positive quarter for VFF,” and that with the Canadian cannabis market growing, it puts Village in a great spot to gain market share and revenue growth further.

Sarugaser says, “VFF’s 3-month performance currently inline with the HMMJ Index, while—for the reasons outlined above—we expect VFF to break away from the pack,” and believes that currently only 82.8% of Pure Sunfarms revenue is attributed to Village during the third quarter, which moves to 100% for the first quarter of 2021. He says that “VFF beginning to consolidate its revenues with PSF in 1Q20 will be catalytic for the stock.”

Within the segmented forecasts, which are all in US dollars, Sarugaser believes that the third-quarter total revenue will be drop to $41.8 million. As both US Produce Revenue, and Canada Produce Revenue are expected to be down due to COVID-19. Raymond James is currently forecasting segment revenue to be $33.8 million and $7.8 million for the third quarter, respectively, down from $37 million and $10.5 million.

Finally, Sarugaser forecasts that Pure Sunfarms’ revenue will be $10.8 million, through the sale of 12,726 kilograms of cannabis, up from 10,365 last quarter. Their average selling price is estimated to have gone lower from $0.91 to $0.85, although this is partially offset by the all-in cost of goods sold going lower to $0.58 from $0.61.

The average selling price is forecasted to rebound in the fourth quarter to $1.00 and eventually go up to $1.15 at the end of 2021, while their cost of goods sold is estimated to go up to $0.67, but end up slightly higher at $0.63 by the end of 2021.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

How to Still Find 10-Bagger Gold and Silver Stocks | Don Durrett

First Majestic Silver: Jerritt Canyon Is BACK!

Canada May Finally Be Backing Its Battery Supply Chain | John Passalacqua – First Phosphate

Recommended

Questcorp’s La Union Surface Program Delivers 20 g/t Gold Over 2.9 Metres In Channel Sample

Kirkland Lake Discoveries Drills 39.35 g/t Gold Over 16.4 Metres As Mirado Continues To Grow

Related News

BMO Drops Kinross Gold’s Price Target On Messy Q1 Results

On Monday Kinross Gold (TSX: K) reported its first quarter financial results. The company saw...

Thursday, May 12, 2022, 12:24:00 PM

Meta Platforms: Canaccord Anticipates Headwinds To Persist, Cuts Target To $200

On October 26th, Meta Platforms Inc (Nasdaq: META) reported its third-quarter financial results. The company...

Thursday, November 3, 2022, 12:52:00 PM

Antibe Therapeutics: Canaccord Initiates Coverage, Issues $1.50 Price Target

Recently, Canaccord Genuity’s Tania Gonsalves initiated coverage on Antibe Therapeutics (TSXV: ATE), a biotechnology company...

Tuesday, August 18, 2020, 01:46:28 PM

Stifel-GMP: “White House Actions Could Catalyze A Secular Cannabis Bull Market”

Yesterday, US President Joe Biden announced that he is taking steps to make right what...

Friday, October 7, 2022, 02:18:00 PM

Facebook Blows Analyst Expectations Away With Strong Results

Facebook Inc (NASDAQ: FB) opened 8% higher Thursday morning, reaching record highs and closing in...

Saturday, May 1, 2021, 03:34:00 PM